These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12413817)

  • 1. Models of intellectual property.
    Crespi S
    Trends Biotechnol; 2002 Nov; 20(11):451. PubMed ID: 12413817
    [No Abstract]   [Full Text] [Related]  

  • 2. Needed: models of biotechnology intellectual property.
    Gold ER; Castle D; Cloutier LM; Daar AS; Smith PJ
    Trends Biotechnol; 2002 Aug; 20(8):327-9. PubMed ID: 12127278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patents, innovation, and privatization: Commentary on: "Data management in academic settings: an intellectual property perspective".
    Albin RC
    Sci Eng Ethics; 2010 Dec; 16(4):777-81. PubMed ID: 20882419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property protection of plant biotechnology inventions.
    Sechley KA; Schroeder H
    Trends Biotechnol; 2002 Nov; 20(11):456-61. PubMed ID: 12413819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing genetic material to protect intellectual property rights.
    Jong SC; Cypess RH
    J Ind Microbiol Biotechnol; 1998 Feb; 20(2):95-100. PubMed ID: 9611821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the impact of the European unitary patent system on worldwide biotechnology.
    Belda I; Penas G; Marquina D; Santos A
    Trends Biotechnol; 2014 Aug; 32(8):393-5. PubMed ID: 25059513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 9. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
    Jakas J
    Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 11. International patent law-boon or bane of biotech?
    Basu P
    Nat Biotechnol; 2005 Jan; 23(1):13-5. PubMed ID: 15637604
    [No Abstract]   [Full Text] [Related]  

  • 12. Intellectual property law in biotechnology.
    Okada-Takagi M
    Med Law; 1997; 16(1):9-16. PubMed ID: 9212598
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnology and intellectual property. Part 2: Microorganism deposit questions and agricultural biotechnology issues.
    Crespi RS
    Trends Biotechnol; 1991 May; 9(5):151-7. PubMed ID: 1367282
    [No Abstract]   [Full Text] [Related]  

  • 14. International intellectual property strategies for therapeutic antibodies.
    Storz U
    MAbs; 2011; 3(6):596-606. PubMed ID: 22123063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts brewing as phage display gets complex.
    Glaser V
    Nat Biotechnol; 1997 Jun; 15(6):506. PubMed ID: 9181564
    [No Abstract]   [Full Text] [Related]  

  • 17. Patenting for the research scientist: an update.
    Crespi RS
    Trends Biotechnol; 2004 Dec; 22(12):638-42. PubMed ID: 15542154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual property. Plants and intellectual property: an international appraisal.
    Koo B; Nottenburg C; Pardey PG
    Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646
    [No Abstract]   [Full Text] [Related]  

  • 19. Navigating the future(s) of biotech intellectual property.
    Cukier KN
    Nat Biotechnol; 2006 Mar; 24(3):249-51. PubMed ID: 16525371
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.